Cargando…

Role of Circulating Angiotensin Converting Enzyme 2 in Left Ventricular Remodeling following Myocardial Infarction: A Prospective Controlled Study

Angiotensin-converting enzyme 2 (ACE2) cleaves Angiotensin-II to Angiotensin-(1–7), a cardioprotective peptide. Serum soluble ACE2 (sACE2) activity is raised in chronic heart failure, suggesting a compensatory role in left ventricular dysfunction. Our aim was to study the relationship between sACE2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ortiz-Pérez, José T., Riera, Marta, Bosch, Xavier, De Caralt, Teresa M., Perea, Rosario J., Pascual, Julio, Soler, María José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632515/ https://www.ncbi.nlm.nih.gov/pubmed/23630610 http://dx.doi.org/10.1371/journal.pone.0061695

Ejemplares similares

Serum ACE2 activity correlates with infarct size and left ventricular dysfunction during acute myocardial infarction
por: Ortiz Pérez, José T, et al.
Publicado: (2011)

Circulating angiotensin converting enzyme 2 and COVID-19
por: Leowattana, Wattana, et al.
Publicado: (2022)

Angiotensin Converting Enzymes
por: Wong, Marty K.S.
Publicado: (2016)

Angiotensin converting enzyme
por: Wong, Marty Kwok-Shing
Publicado: (2021)

Tenascin‐C aggravates ventricular dilatation and angiotensin‐converting enzyme activity after myocardial infarction in mice
por: Santer, David, et al.
Publicado: (2020)

Angiotensin-converting enzyme genetic polymorphism: its impact on cardiac remodeling
por: de Albuquerque, Felipe Neves, et al.
Publicado: (2014)

Considerations for Docking of Selective Angiotensin-Converting Enzyme Inhibitors
por: Caballero, Julio
Publicado: (2020)

Angiotensin-Converting Enzyme-2
por: Clarke, Nicola E., et al.
Publicado: (2013)

Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism
por: Meurs, Kathryn M, et al.
Publicado: (2017)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
por: Vio, Carlos P., et al.
Publicado: (2020)

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

The Gene Polymorphism of Angiotensin-Converting Enzyme Intron Deletion and Angiotensin-Converting Enzyme G2350A in Patients With Left Ventricular Hypertrophy: A Meta-analysis
por: Fajar, Jonny Karunia, et al.
Publicado: (2019)

Angiotensin Converting Enzyme Inhibitors versus Receptor Blockers in Patients with Ventricular Tachyarrhythmias
por: Schupp, Tobias, et al.
Publicado: (2022)

Increase in prescription rate of angiotensin-converting enzyme inhibitors or angiotensin receptor blocker for hospitalized patients with acute myocardial infarction and left ventricular systolic dysfunction
por: Makdisse, MRP, et al.
Publicado: (2007)

Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Prothrombotic Processes and Myocardial Infarction Risk
por: Dézsi, Csaba András, et al.
Publicado: (2016)

Association of circulating angiotensin converting enzyme activity with respiratory muscle function in infants
por: Dimitriou, Gabriel, et al.
Publicado: (2010)

Determinants of circulating angiotensin-converting enzyme 2 protein levels in the general population
por: Kuznetsova, Tatiana, et al.
Publicado: (2021)

Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Gersh, Felice L.
Publicado: (2020)

Angiotensin-Converting Enzyme Inhibitors and Angioedema
por: Sánchez-Borges, Mario, et al.
Publicado: (2010)

Angiotensin-converting Enzyme Genetic Polymorphism
por: Wiwanitkit, Somsri, et al.
Publicado: (2014)

Prediction of left ventricular reverse remodeling after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy
por: Matsumura, Yoshihisa, et al.
Publicado: (2015)

Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: Anti-arrhythmic Drug for Arrhythmogenic Right Ventricular Cardiomyopathy
por: Tu, Bin, et al.
Publicado: (2021)

In reply—Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Renin‐angiotensin aldosterone profile before and after angiotensin‐converting enzyme‐inhibitor administration in dogs with angiotensin‐converting enzyme gene polymorphism
por: Adin, Darcy, et al.
Publicado: (2020)

Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Withdrawal Is Associated with Higher Mortality in Hospitalized Patients with COVID-19
por: Roy-Vallejo, Emilia, et al.
Publicado: (2021)

Comparison of clinical outcomes of angiotensin receptor blockers with angiotensin-converting enzyme inhibitors in patients with acute myocardial infarction
por: Chen, Chih-Wei, et al.
Publicado: (2023)

Angiotensin-converting-enzyme inhibitor prevents skeletal muscle fibrosis in myocardial infarction mice
por: Kakutani, Naoya, et al.
Publicado: (2020)

Expression of circulating angiotensin‐converting enzyme 2 in children with asthma and the effects of inhaled corticosteroids
por: Ma, Xiang, et al.
Publicado: (2023)

Intrarenal Distributions and Changes of Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 in Feline and Canine Chronic Kidney Disease
por: MITANI, Sawane, et al.
Publicado: (2013)

Determination of soluble angiotensin-converting enzyme 2 in saliva samples and its association with nicotine
por: Bru, Samuel, et al.
Publicado: (2023)

Urinary angiotensin-converting enzyme 2 and metabolomics in COVID-19-mediated kidney injury
por: Vergara, Ander, et al.
Publicado: (2022)

Angiotensin-Converting Enzyme 2: The First Decade
por: Clarke, Nicola E., et al.
Publicado: (2012)

Angiotensin-I-converting enzyme and its relatives
por: Riordan, James F
Publicado: (2003)

Serum Angiotensin Converting Enzyme in Pemphigus Vulgaris
por: Robati, Reza M, et al.
Publicado: (2014)

Angiotensin Converting Enzyme Activity in Alopecia Areata
por: Namazi, Mohammad Reza, et al.
Publicado: (2014)

Angiotensin-converting enzyme 2 in lung diseases
por: Kuba, Keiji, et al.
Publicado: (2006)

Angiotensin converting enzyme polymorphism and ischemic stroke
por: Salem, Gelan M., et al.
Publicado: (2020)

Angiotensin-converting-enzyme inhibitor–induced angioedema
por: Quickfall, Danica, et al.
Publicado: (2021)

Interaction Between Angiotensin-Converting Enzyme Gene Insertion/Deletion Polymorphism and Angiotensin-Converting Enzyme Inhibition on Survival in Hemodialyzed Patients
por: Kiss, István, et al.
Publicado: (2014)

Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Angiotensin-Converting Enzyme 2 Levels: A Comprehensive Analysis Based on Animal Studies
por: Kriszta, Gábor, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p6t52rq0bh9qjhsdee14cnifdi